Finns link heart attacks to renegade antibodies
This article was originally published in Clinica
Executive Summary
Data from the Helsinki Heart Study represent the strongest evidence yet that renegade antibodies play a role in heart attacks. The finding comes from the first prospective study of anti-cardiolipin antibodies (aCL) as a predictor of myocardial infarction in middle-aged men (Circulation, January 1st).